I had some free time this afternoon and did some research on who was distributing Fillerina in Australia.
My ferreting took me to:
MyFillerina
50/23 Narabang Way (725.89 km)
2085 Belrose, New South Wales
1300 068 357
( source: Web Search. See important info about your result at http://m.ws.1234.com.au )
I randomly called the company and Hugh got the phone. After asking a few leading questions about the product and distribution; Hugh informed me his parent company http://www.aventionglobal.com/ has the exclusive rights to distribute Fillerina products in Australia and New Zealand.
I asked Hugh if he had ever heard of Cellmid or Advangen or Evolis and he said none of the names sound familiar to him.
I then went on to ask Hugh if he was aware of a recent asx announcement by Cellmid informing the market that Advangen had secured the exclusive distribution rights to the products. He was unaware of this so I sent him the asx announcement and we agree to chat 30 minutes later.
I phoned Hugh back and he advised that after speaking with the owner of the parent company they have sent an email to Labo for an explanation as they aren’t aware of anything.
The CEO is https://www.linkedin.com/in/stephaniesherlock/
Mobile number is also listed for Stephanie if anyone else wants to call her.
Hugh informed me that aventionglobal.com presumably would have a water tight contract for exclusive distribution?
Anyway, I emailed Maria asking for a reply and advised if I didn’t hear back from her I would put it to the forum and seek a possible explanation.
Any thoughts?
On a positive note Hugh did say the product has very strong customer loyalty and reoccurring sales. They have plenty of stock in the warehouse to meet strong demand.
https://architectsofskin.com.au
- Forums
- ASX - By Stock
- AN1
- fillerina
fillerina, page-22
-
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1457234 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 340000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1457234 | 0.008 |
2 | 1111500 | 0.007 |
5 | 1021527 | 0.006 |
1 | 300000 | 0.005 |
2 | 525000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 340000 | 1 |
0.011 | 100000 | 1 |
0.012 | 100000 | 1 |
0.013 | 750000 | 1 |
0.015 | 440000 | 3 |
Last trade - 16.12pm 15/07/2024 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online